[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease

MLA

Shiaw-Pyng Wey, et al. “[18F]FP-(+)-DTBZ PET Study in a Lactacystin-Treated Rat Model of Parkinson Disease.” Annals of Nuclear Medicine, vol. 31, Apr. 2017, pp. 506–13. EBSCOhost, https://doi.org/10.1007/s12149-017-1174-3.

APA

Shiaw-Pyng Wey, Mei-Ping Kung, Tzu-Chen Yen, Ching-Han Hsu, Siao-Lan Huang, Ing-Tsung Hsiao, Chi-Chang Weng, Kun-Ju Lin, & Zi-An Chen. (2017). [18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease. Annals of Nuclear Medicine, 31, 506–513. https://doi.org/10.1007/s12149-017-1174-3

Chicago

Shiaw-Pyng Wey, Mei-Ping Kung, Tzu-Chen Yen, Ching-Han Hsu, Siao-Lan Huang, Ing-Tsung Hsiao, Chi-Chang Weng, Kun-Ju Lin, and Zi-An Chen. 2017. “[18F]FP-(+)-DTBZ PET Study in a Lactacystin-Treated Rat Model of Parkinson Disease.” Annals of Nuclear Medicine 31 (April): 506–13. doi:10.1007/s12149-017-1174-3.